Skip to main content
Premium Trial:

Request an Annual Quote

Bankruptcy Court Allows Decode Genetics to Continue Operations

NEW YORK (GenomeWeb News) – Decode Genetics today said that the US Bankruptcy Court for the District of Delaware has approved "first day" motions for the firm's petition for relief under Chapter 11 filed last week.

Decode said that the court has allowed the firm to continue operating during the Chapter 11 proceedings. The court also granted interim approval for the firm's debtor-in-possession financing from Saga Investments.

Decode had said in the filing last week that it has reached an agreement to sell its Iceland-based subsidiary Islensk Erfdagreining (IE), and its drug discovery and development programs to Saga, which has backing from venture capital firms Polaris Venture Partners and Arch Venture Partners.

The Scan

CDC Calls Delta "Variant of Concern"

CNN reports the US Centers for Disease Control and Prevention now considers the Delta variant of SARS-CoV-2 to be a "variant of concern."

From FDA to Venture Capital

Former FDA Commissioner Stephen Hahn is taking a position at a venture capital firm, leading some ethicists to raise eyebrows, according to the Washington Post.

Consent Questions

Nature News writes that there are questions whether informed consent was obtained for some submissions to a database of Y-chromosome profiles.

Cell Studies on Multimodal Single-Cell Analysis, Coronaviruses in Bats, Urban Microbiomes

In Cell this week: approach to analyze multimodal single-cell genomic data, analysis of bat coronaviruses, and more.